sulfur mustard

(redirected from Sulfur mustard gas)
Also found in: Dictionary, Thesaurus.
Related to Sulfur mustard gas: lewisite gas

mus·tard gas (HD),

a poisonous vesicating gas introduced in World War I; it is the progenitor of the so-called nitrogen mustards; used in chemical warfare; a known carcinogen.
Synonym(s): di, mustard (2) , sulfur mustard

sul·fur mustard

(sŭl'fŭr mŭs'tărd)
A vesicating chemical-warfare agent used extensively in World War I (1914-1918) and thereafter and sometimes called "mustard gas," a misnomer because it does not boil until 217°C (423°F). The NATO code for the impure sulfur mustard prepared by the Löwenstein process used in World War I is H; the NATO code for neat, or distilled, sulfur mustard is HD.

mustard

an irritant compound derived from the dried ripe seed of Brassica (Sinapis) alba, B. nigra or B. juncea. Contains toxic allyl isothiocyanate in nontoxic glycoside form, though the plant also contains myrosinase, an enzyme that converts the glycoside to the toxic form. Used as a carminative, emetic and counterirritant in poultices.

mustard gas
one of several gases used in military activities, e.g. dichlorodiethylsulfide. Causes vesication of skin, blindness due to corneal damage, and pulmonary edema if inhaled.
mustard greens
green foliage of several mustard-type plants, used in salads.
mustard oil
present in high concentrations in mustard plants and causes acute indigestion in animals.
mustard oil glucosinolates
toxic oil glucosinolates found in plants.
sulfur mustard
a synthetic compound with vesicant and other toxic properties.
tansy mustard
References in periodicals archive ?
The Company currently has eight studies in progress including studies of AEOL 10150 as a potential countermeasure against the effects of: radiation on the lungs in mice and non-human primates and the gastro-intestinal tract in mice, chlorine gas on the lungs in mice and sulfur mustard gas on the lungs in rats and skin in mice, and studies of AEOL 11207 as a potential treatment for epilepsy and for Parkinson's disease.
Preclinical expenses also increased over the comparable period in 2009 due to increased animal study activity to support the Company's ARS development program The Company currently has eight studies in progress including studies of AEOL 10150 as a potential countermeasure against the effects of: radiation on the lungs in mice and non-human primates and the gastro-intestinal tract in mice, chlorine gas on the lungs in mice and sulfur mustard gas on the lungs in rats and skin in mice, and studies of AEOL 11207 as a potential treatment for epilepsy and for Parkinson's disease.
as a medical countermeasure against the effects of sulfur mustard gas on the lungs,
Studies funded by the National Institutes for Health are currently underway evaluating AEOL 10150 as a treatment for exposure to radiation, sulfur mustard gas and chlorine gas.
AEOL 10150 offers several unique advantages as a countermeasure for the treatment of ARS, sulfur mustard gas and chlorine gas for civilian and military populations.
ARS, sulfur mustard gas and chlorine gas) and multiple syndromes within ARS (pulmonary and gastrointestinal) establish its potential to offer an increase in capability compared with currently available countermeasures.
The new studies will be conducted using "whole" sulfur mustard gas and build on results from previous studies using CEES, an analog of mustard gas, which were conducted at National Jewish Health and the University of Colorado.
These tests will all be done in a Lovelace lab equipped to safely study dangerous chemical warfare agents like sulfur mustard gas.
The Ilomastat selection for evaluation in the sulfur mustard gas grant from the NIH should not be construed by any means as an indication of the present or future value of the Company or its common stock.